claim: elevated calprotectin and abnormal myeloid cell subsets discriminate naturally from mild covid-19
evidence_1: finally, we show that calprotectin plasma level and a routine flow cytometry assay detecting decreased frequencies of non-classical monocytes could discriminate patients who develop a severe form of covid-19, suggesting a predictive value that deserves prospective evaluation.